Source: Annual Congress 2005 - Respiratory infections and inflammations
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
C. Shao, J. Qu, L. He, Y. Zhang, J. Wang, Y. Wang, H. Zhou, X. Liu (Shanghai, China). Transient overexpression of gamma interferon promotes Aspergillus clearance in invasive pulmonary aspergillosis. Eur Respir J 2005; 26: Suppl. 49, 2602

Member's Comments

No comment yet.

Related content which might interest you: Interferon-γ therapy in two patients with progressive chronic pulmonary aspergillosis Source: Eur Respir J 2006; 27: 1307-1310 Year: 2006 In-vivo and in-vitro production of interferon gamma in pediatric patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 140s Year: 2002 Remarkably efficient inhaled antifungal monotherapy for invasive pulmonary aspergillosis Source: Eur Respir J 2012; 40: 271-273 Year: 2012 Regulatory T cells and inhibitory receptor expression in chronic pulmonary aspergillosis patients Source: International Congress 2017 – From microbiology to clinical work Year: 2017 Over-expression of thymosin beta4 in granulomatous lung lesions in active pulmonary tuberculosis Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools Year: 2012 Role and regulation of moraxella catarrhalis-induced beta defensin 3 expression in human pulmonary epithelial cells Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008 PET‘s importance in chronic pulmonary aspergillosis Source: Eur Respir J 2006; 28: Suppl. 50, 560s Year: 2006 Treatment outcome in patients with chronic pulmonary aspergillosis by azole-resistant aspergillus fumigatus Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016 Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation Source: Eur Respir J, 53 (3) 1801184; 10.1183/13993003.01184-2018 Year: 2019 Comparison of clinical characteristics of invasive tracheobronchial aspergillosis with or without invasive pulmonary aspergillosis Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019 CSF1R inhibition prevents radiation pulmonary fibrosis by depletion of interstitial macrophages Source: Eur Respir J, 51 (3) 1702120; 10.1183/13993003.02120-2017 Year: 2018 Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma Source: Eur Respir J 2011; 37: 865-872 Year: 2011 Caspofungin to treat invasive pulmonary aspergillosis in sarcoidosis Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Inhaled IFN-γ for persistent nontuberculous mycobacterial pulmonary disease due to functional IFN-γ deficiency Source: Eur Respir J 2004; 24: 367-370 Year: 2004 Intrabronchial activated protein C enhances lipopolysaccharide-induced pulmonary responses Source: Eur Respir J 2013; 42: 188-197 Year: 2013 Role of NF-κB p50 in bleomycin induced pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 192s Year: 2006 Heterologous infection causes pneumonia and impairs alveolar macrophage function in mice Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008 Invasive pulmonary aspergillosis in patients with severe COPD. Compative study between probable invasive infection and colonization Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Transient over-expression of bioactive PDGF-BB induces lung fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 152s Year: 2006 Impact of Aspergillus fumigatus infection on lung function in children with cystic fibrosis Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021